Top Story

Cancer diagnosis may encourage smoking cessation

May 27, 2015

The receipt of a cancer diagnosis was associated with sustained smoking cessation regardless of the cancer’s prognosis or relation to smoking, according to study results.

 “This is the first study to our knowledge to show that a cancer diagnosis, even for cancers not strongly related to smoking, can lead to higher quit rates,” J. Lee Westmaas, PhD, of the Behavioral Research Center at the American Cancer Society, said in a press release. “It appears a cancer diagnosis acts as a sort of ‘cue-to-action’ that leads smokers to quit.”

In the Journals

Kallikrein markers improve high-grade prostate cancer detection, reduce unnecessary biopsies

May 25, 2015
A statistical model using kallikrein markers better predicted high-grade prostate cancer in men with elevated PSA levels and reduced unnecessary biopsies compared with…
Arul M. Chinnaiyan, MD, PhD Cover StoryPublication Exclusive

Despite promise, ‘maximum potential’ of precision medicine yet to be reached

HemOnc Today, May 25, 2015
Precision medicine has garnered tremendous public attention since President Barack Obama established it as a national priority during his State of the Union address.The…
In the Journals

Cixutumumab fails to enhance activity of ADT in prostate cancer

May 20, 2015
The addition of cixutumumab to androgen deprivation therapy did not significantly increase the undetectable PSA rate in patients with new metastatic hormone-sensitive…
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Video
thumbnail for video 4040822599001

Routine PSA screening for most men not ready for ‘prime time’

February 10, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
In the Journals

Cancer diagnosis may encourage smoking cessation

May 27, 2015
The receipt of a cancer diagnosis was associated with sustained smoking cessation regardless of the cancer’s prognosis or relation to smoking…
In the Journals

Kallikrein markers improve high-grade prostate cancer detection, reduce unnecessary biopsies

May 25, 2015
A statistical model using kallikrein markers better predicted high-grade prostate cancer in men with elevated PSA levels and reduced unnecessary…
Arul M. Chinnaiyan, MD, PhD Cover StoryPublication Exclusive

Despite promise, ‘maximum potential’ of precision medicine yet to be reached

HemOnc Today, May 25, 2015
Precision medicine has garnered tremendous public attention since President Barack Obama established it as a national priority during his State of…
In the Journals

Cixutumumab fails to enhance activity of ADT in prostate cancer

May 20, 2015
The addition of cixutumumab to androgen deprivation therapy did not significantly increase the undetectable PSA rate in patients with new metastatic…
Meeting News CoveragePerspective

Docetaxel improves survival for men with hormone-naive prostate cancer

May 14, 2015
The addition of docetaxel to standard therapy clinically and significantly improved survival for men with locally advanced or metastatic…

When should men undergo PSA screening?

May 13, 2015
The most recent U.S. Preventive Services Task Force recommendation suggests healthy men should not undergo PSA screening for prostate cancer…
In the Journals

IMRT, 3D-CRT confer similar patient-reported outcomes in prostate cancer

May 12, 2015
Intensity-modulated radiation therapy was not associated with improved patient-reported bowel, bladder and sexual function outcomes compared with…
Philip W. Kantoff, MD In the JournalsPerspective

Statin use before ADT delays prostate cancer progression

May 8, 2015
Men with prostate cancer who used statins at the initiation of androgen deprivation therapy demonstrated a delayed time to progression, according to…
VIDEO: Updates in prostate cancer treatment options Meeting News CoverageVideo

VIDEO: Updates in prostate cancer treatment options

May 5, 2015
Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, discusses various forms of prostate cancer, along with the value of…
Howard I. Scher, MD In the Journals

CTC, LDH biomarker panel serves as surrogate for prostate cancer survival

May 5, 2015
A biomarker panel composed of circulating tumor cell number and lactate dehydrogenase level accurately served as a surrogate for survival in men with…
More Headlines »
morganatic-roan